Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Leiomyoma 3

Interventions

telapristone acetate 10ulipristal 3asoprisnil 3vilaprisan 2estradiol, norethindrone drug combination 2elagolix 2Norethindrone Acetate 2Mifepristone 2Lidocaine 2Leuprolide 2Estradiol 2ulipristal acetate 1relugolix 1pirfenidone 1epigallocatechin gallate 1Tea 1Sugars 1Simvastatin 1Ropivacaine 1Progesterone 1Morphine 1Methadone 1Injections, Subcutaneous 1Embolization, Therapeutic 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Leiomyoma × asoprisnil × Clear all
NCT00156182 2009-03-04

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

Abbott

Phase 2 Completed
38 enrolled

Leiomyoma

NCT00150644 2008-05-29

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

Abbott

Phase 2 Completed
33 enrolled

Leiomyoma

NCT00160459 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Abbott

Phase 2 Completed
129 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡